Back to Results
First PageMeta Content
Oncology / Immune system / Epithelial cell adhesion molecule / Cancer treatments / Antibody-drug conjugate / Bi-specific T-cell engager / Cancer stem cell / Chemotherapy / Immunotoxin / Medicine / Biology / Monoclonal antibodies


VB6-845 Licensing Opportunity VIVENTIA Bio Inc. VB6-845
Add to Reading List

Document Date: 2013-03-14 08:27:59

Open Document

File Size: 242,94 KB

Share Result on Facebook

City

WINNIPEG / New York / /

Company

VIVENTIA Bio Inc. / Licensing Opportunity VIVENTIA Bio Inc. / CSC / /

Country

Canada / /

/

Facility

Plant Toxin Bouganin / /

IndustryTerm

technology transfer / /

MedicalCondition

EpCAM-positive tumors / tumor / breast cancers / cancer / disease / advanced solid tumor cancers / human tumor / carcinomas / prostate cancers / advanced solid tumors / Solid Tumors / carcinoma / lung cancers / /

MedicalTreatment

Immunotherapy / /

Person

Glen MacDonald / /

/

Technology

Radiopharmaceuticals / Drug Discovery / stem cells / drug development / epithelial tumors VB6-845 Technology / /

URL

www.viventia.com / /

SocialTag